Anti Cathepsin B Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	255 Pages	Coherent Market Insights	August, 2023	CMI18163397

Best Price Guarantee
Price	from $4,500
Length	255 Pages
Publisher	Coherent Market Insights
Published Date	August, 2023
SKU	CMI18163397

Anti Cathepsin B Market, By Product Type, By Application, By Technique, By End User and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Cathepsin B is a cysteine protease found mainly in the lysosomes of normal cells but is secreted or associated with the plasma membrane of many transformed cells. It is found in all animals and other organisms and plays a key role in cellular protein metabolism. The cathepsin family includes serine proteases, aspartic proteases, and cysteine proteases. The aspartyl protease class consists of cathepsins D and E. The cysteine protease class consists of cathepsins B, L, H, K, S, and O. Currently, there are no approved cathepsin inhibitors on the market, but research is ongoing to develop new cathepsin inhibitors for the treatment of various diseases such as cancer, traumatic brain injury, Ebola infection, and others. Anti-Cathespin B antibodies are majorly used for the treatment of disease conditions such as cancer, traumatic brain injury, Ebola infection, and fertility problems, and are currently under research for the treatment of SARS-CoV-2. Cathepsin B is a protease that contributes to the remodeling of the extracellular matrix and thereby promotes keratinocyte migration during wound healing.

Market Dynamics

Increasing practices of treatments, mergers, and acquisitions by key market players are expected to drive the global anti-cathepsin B market growth. For instance, on March 31, 2020, National Center for Biotechnology Information published an article explaining Cathepsin B (CTSB) is an abundant cysteine protease that functions in both endolysosomal compartments and extracellular regions. Many preclinical and clinical studies indicate that CTSB is involved in many human diseases. CTSB expression levels and activity are significantly correlated with disease progression and severity. Current CTSB inhibitors lack sufficient specificity and pharmacological activity. Using structure-based rational design, researchers developed and produced a humanized antibody inhibitor targeting human CTSB.

Key features of the study:

This report provides an in-depth analysis of the global anti-cathepsin B market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global anti-cathepsin B market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Merck KGaA, Bio-Techne, BioVision Inc., Santa Cruz Biotechnology, Inc., MedChemExpress, BioCat GmbH, ApexBio Technology, Cayman Chemical, Selleck Chemicals, BOC Sciences, AG Scientific, Virobay Inc., and Abcam Plc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global anti-cathepsin B market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti-cathepsin B market.

Detailed Segmentation:

Global Anti-Cathepsin B Market, By Product Type :
Primary Antibodies
Proteins and Peptides
Lysates
Global Anti-Cathepsin B Market, By Application :
Cancer
Traumatic Brain Injury
Ebola Infection
Fertility Treatment
Others
Global Anti-Cathepsin B Market, By Technique :
Immunohistochemistry
Immunofluorescence
Western Blotting
ELISA
Flow Cytometry
Others
Global Anti-Cathepsin B Market, By End User
Pharmaceutical Companies
Academic and Research Institutes
Global Anti-Cathepsin B Market, By Region:
North America
U.S.
Canada
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC
Israel
Rest of Middle East
Africa
South Africa
Central Africa
North Africa
Company Profiles
Merck KGaA
Bio-Techne
BioVision Inc.
Santa Cruz Biotechnology, Inc.
MedChemExpress
BioCat GmbH
ApexBio Technology
Cayman Chemical
Selleck Chemicals
BOC Sciences
AG Scientific
Virobay Inc.
Abcam Plc.

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Product Type; Market Snapshot, By Application; Market Snapshot, By Technique; Market Snapshot, By End User; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Restraints; Market Opportunities; Impact Analysis; Recent Product Launches; Epidemiology; Merger, Acquisition, and Collaborations; Regulatory Scenario; Key Developments; PEST Analysis
4. Global Anti-Cathepsin B Market – COVID-19 Impact Analysis: Economic Impact; COVID-19 Epidemiology; Impact on Supply and Demand
5. Global Anti-Cathepsin B Market, By Product Type, 2018–2030, (US$ Million): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018–2030; Segment Trends; Primary Antibodies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Proteins and Peptides; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Lysates; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
6. Global Anti-Cathepsin B Market, By Application, 2018–2030, (US$ Million): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018–2030; Segment Trends; Cancer; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Traumatic Brain Injury; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Ebola Infection; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Fertility Treatment; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
7. Global Anti-Cathepsin B Market, By Technique, 2018–2030, (US$ Million): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018–2030; Segment Trends; Immunohistochemistry; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Immunofluorescence; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Western Blotting; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018–2030; Segment Trends; ELISA; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018–2030; Segment Trends; Flow Cytometry; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018–2030; Segment Trends; Others; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018–2030; Segment Trends
8. Global Anti-Cathepsin B Market, By End User, 2018–2030, (US$ Million): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018–2030; Segment Trends; Pharmaceutical Companies; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018–2030; Segment Trends; Academic and Research Institutes; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018–2030; Segment Trends
9. Global Anti-Cathepsin B Market, By Region, 2018–2030, (US$ Million): Introduction; Market Share Analysis, By Region, 2023 and 2030 (%); Y-o-Y Growth Analysis, For Region, 2018–2030; Regional Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Million); U.S.; Canada; Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Million); Brazil; Mexico; Argentina; Rest of Latin America; Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Million); U.K.; Germany; Italy; France; Spain; Russia; Rest of Europe; Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Million); China; India; Japan; ASEAN; Australia; South Korea; Rest of Asia Pacific; Middle East; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Million); GCC; Israel; Rest of Middle East; Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018–2030, (US$ Million); North Africa; Central Africa; South Africa
10. Competitive Landscape: Merck KGaA; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Bio-Techne; BioVision Inc; Santa Cruz Biotechnology, Inc; MedChemExpress; BioCat GmbH; ApexBio Technology; Cayman Chemical; Selleck Chemicals; BOC Sciences; AG Scientific; Virobay Inc; Abcam Plc
11. Section: Research Methodology; About Us; *Browse 40 market data tables and 48 figures on “Global Anti-Cathepsin B Market”- Global forecast to 2030